Macromolecules of vitellogenin were sequestered by Xenopus laevis oocytes 20-50 times (on a molar basis) more rapidly than other proteins tested. Selectivity for vitellogenin did not appear to involve molecular size or charge. The Km for vitellogenin incorporation was at least several orders of magnitude less than that for bovine serum albumin (BSA). At concentrations less than 10 mg.m1-1, BSA did not measurably compete with vitellogenin; a slight, apparent competition observed above a BSA concentration of 10 mg. ml-1 was probably spurious. Above a concentration of 2 mg. ml-1, vitellogenin promoted BSA incorporation by about 40%. These results are consistent with the notion that vitellogenin binds to specific receptor sites on the oocyte membrane and is subsequently internalized by micropinocytosis. Other proteins, such as BSA, which do not compete with vitellogenin are most likely to be incorporated by adventitious engulfment during micropinocytosis.
Vitellogenin is a normally female-specific protein sequestered from the bloodstream by growing oocytes; it serves as the macromolecular precursor in Xenopus laevis for the yolk proteins lipovitellin and phosvitin (6, 7, 10, 20, 21, 25, 28) which are apparently formed by enzymatic cleavage of vitellogenin within the oocyte (1). Previous experiments have indicated that vitellogenin is more rapidly sequestered than other serum fractions, both in vivo (25) and in vitro (27) , and that incorporation of the protein is essentially linear with time (8, 27) . Selective incorporation of specific proteins by oocytes has also been indicated for other animals (4, 18) . In this communication we report further studies on viteUogenin uptake by X. laevis oocytes in vitro, both in comparison with and in the presence of other purified proteins. Quantitative and kinetic measurements confirm that vitellogenin uptake is a highly selective process, and that under physiological conditions other proteins essentially do not compete with vitellogenin.
MATERIALS AND METHODS
Procedures for handling animals, injecting isotopes and hormones, and bleeding have been described elsewhere (24) . Blood was collected into a citrate solution containing phenylmethyl sulfonyl fluoride, and sterile glassware and buffer solutions were used in subsequent steps in order to minimize proteolysis of vitellogenin (1). Vitellogenin was obtained in pure form by chromatography of plasma from estrogen-treated females (1 mg estradiol-17/5'.50 g-~ body weight given 7 days previously) on TEAE-cellulose (20) . Vitellogenin was labeled in vivo by injecting an estrogen-treated female with 100 ~Ci of l~4Clleucine 24 h before bleeding. Proteins (Sigma Chemical Co., St. Louis, Mo.) were labeled in vitro by THE JOURNAL OF CELL BIOLOGY 9 VOLUME 69, 1976 9 pages 345-351reductive alkylation with [l'C]formaldehyde: the method published by Rice and Means (11) was used except that the concentration of protein alkylated was 10-fold higher. Alkylated proteins were exhaustively dialyzed to a constant specific activity. Protein concentrations were determined by the method of Bramhall et al. (2) , using Lab. Trol (Dade Div., American Hospital Supply Corp., Miami, Fla.) as a standard. Polyacrylamide gel electrophoresis was performed as described previously (1).
Oocytes (0.9-1.0 mm) were isolated (8) from females given 1,000 U of human chorionic gonadotropin within the week before isolation (27) and were incubated at 20~ in solution O-R2 (26) containing the indicated proteins. The oocytes were incubated for 18 h, then washed, measured, dissolved in NCS (Nuclear Chicago, Amersham/Searle Corp., Arlington Heights, I11.), and counted in a liquid scintillation counter at 80-85% efficiency (27) . Protein uptake is quantitated as nanograms incorporated per square millimeter oocyte surface area per hour. This parameter is relatively constant throughout the size range of oocytes we have used from a given female, but varies somewhat from animal to animal (27) .
R E S U L T S

Effect of A lkylation on Vitellogenin Size Dispersity and Incorporation
It was necessary to label a variety of proteins in vitro to obtain products with the requisite specific activity, and since the incorporation of these proteins was to be compared with that of vitellogenin, it was also desirable to label vitellogenin in a similar manner. SDS-polyacrylamide electrophoresis of alkylated vitellogenin indicated that the modified vitellogenin peptide migrated with the same mobility as the unmodified peptide (tool wt = 200,000; see reference 1) and that no aggregates were produced (Fig. 1) . To discover the effect of labeling in vitro on the uptake of vitellogenin by the oocyte, we labeled viteilogenin in vivo in our usual way and compared its incorporation to that of alkylated vitellogenin. The results (Fig. 2) indicated that the Vmax for alkylated vitellogenin (130 n g . m m -2 . h -1) was 83% that of "native" vitellogenin (156 n g . m m -2 . h -1) and that the relative Kms for the two proteins were within a few percent of one another (0.69 and 0.65 mg. m1-1, respectively). Thus, no pronounced alterations in size dispersity or uptake of alkylated vitellogenin by oocytes were indicated, and the alkylated product was used in the comparative experiments reported below. FIGURE 1 Electrophoretic patterns of vitellogenin (left) and aikylated vitellogenin (right) on SDS-polyacrylamide gels (5% acrylamide, 0, 1% sodium dodecyl sulfate). The top and the bottom of the gels are the origins and tracking dye (bromphenol blue) position, respectively; the ruled lines are 5 mm apart. Protein is stained with Coomassie brilliant blue.
Specificity of Vitellogenin Uptake
Several purified proteins were alkylated with Lt'Clformaldehyde, and their uptakes were compared with that of alkylated vitellogenin (Table I ). The extent of alkylation varied with the individual protein, presumably due to the relative availability of exposed free amino groups. All proteins were adjusted to approximately the same concentration in solution O-R2 and incubated with oocytes from the same female for 18 h, after which the oocytes were washed and counted. The results, when corrected for absolute amounts of protein incorporated, indicated that the various proteins tested were sequestered anywhere from 60 to 100 times more slowly, on a weight basis, than vitellogenin (Table I) . If a molar basis is used, individual molecules of the various proteins were incorporated 20-50 times more slowly than vitellogenin. In the experiments reported below, we have explored in more detail the relative incorporation of and possible competitive relationship between one of the above proteins and vitellogenin.
Vitellogenin Incorporation as a Function of Concentration: Competition with Bovine Serum Albumin (BSA)
Oocytes from the same female were incubated with p'C]vitellogenin at various concentrations, in both the absence and the presence of I0 mg* ml-1 of unlabeled BSA. The rate of p'C]vitellogenin incorporation as a function of concentration was found to follow typical saturation kinetics. A reciprocal plot of the data (Fig. 3 ) indicated that BSA at a level of 10 mg.m1-1 did not compete with p'C]vitellogenin uptake even at very tow concentrations of [~'C]vitellogenin. Vma~ for this particular batch of oocytes was 133 ng-m m -2. hand the K= was 0.69 mg-ml -* (1.5.10 -e M). Using other batches of oocytes, we have found that V=,~ will vary to some extent with the female donor but that K= remains relatively constant.
In a second series of experiments, we held the concentration of p'C] vitellogenin constant at 2.9 mg. ml-t and increased the concentration of unlabeled BSA to ascertain at what level BSA began to compete or interfere with [a'C]vitellogenin incorporation. The results (Fig. 4) indicated that above a concentration of 10 mg.m1-1, BSA indeed affected p~C]vitellogenin uptake, but the competition was only minimal: at a BSA concentration more than 10 times that of p'C]vitellogenin, [l'C]vitellogenin uptake was still about 80% of the control values.
BSA Incorporation as a Function of Concentration: Competition with Vitellogenin
Oocytes vitellogenin. In the absence of vitellogenin, the rate of [I~C]BSA incorporation as a function of concentration appeared to follow a sigmoid curve (Fig, 5 a) . The addition of a large excess of viteltogenin to the medium did not inhibit the uptake of p~C]BSA, but rater stimulated incorporation (Fig. 5 a) . Reciprocal plots ( K,, of 8.3 mg.m1-1 (1.2.10 -~ M) could be calculated. In the absence of vitellogenin a reciprocal plot did not yield a straight line, and the data for p~C]BSA concentrations above 0.5 mg.ml -~ tended to intercept the abscissa somewhere between -0.12 and zero. In other words, the K,~ for p~C]BSA uptake in the absence of vitellogenin was somewhere between 1.2.10 -4 M and infinity.
In another series of experiments, we held the concentration of p'C]BSA constant at 2.7 mg-m1-1 and varied the concentration of unlabeled vitellogenin. Again, it was noted that addition of vitellogenin to the medium promoted p'C]BSA uptake until the vitellogenin concentration reached about 2.0 mg.ml-' (Fig. 6) . Above this concentration, the uptake of labeled BSA plateaued at a rate about 40% greater than that found in the absence of vitellogenin.
DISCUSSION
In this study we have treated protein incorporation into oocytes according to classic concepts devel. oped for enzyme-catalyzed reactions (9) , with protein in the medium as "substrate" and incorporated protein as the "product." Although this represents a simplistic approach to an undoubtedly complicated process, we believe that it represents a necessary first step towards understanding the mechanisms involved. The criteria which allow this treatment are: (a) under the experimental conditions used, only a small fraction of the protein in the medium is incorporated by oocytes (even at the lowest vitellogenin concentrations, more than 90% of the labeled protein remained in the medium after incubation); (b) the amount of protein bound to the cell surface at any given time is less than 1% of the total incorporation measured (26); (c) uptake of protein is essentially linear with time during the period of incubation (8, 27) ; (d) protein incorporated into the oocyte is "fixed," i.e. it is not subsequently lost from the oocyte, broken down and reincorporated into other protein, etc.; and (e) the incorporation process is both markedly temperature dependent (26) and, as shown here, saturable when a specific substrate (vitellogenin) is used.
In general terms, we have observed that amphibian oocytes incorporate vitellogenin much more rapidly than other proteins tested. This was reflected by the relative incorporation of various proteins at the same concentration and was specifically reflected by the relative Km values for BSA and vitellogenin uptake, 1.2-10 -4 M or greater and 1.5.10 -4 M, respectively. The basis for selectivity does not appear to involve molecular size, since vitellogenin molecules are incorporated 60 times more rapidly than ferritin even though both have approximately the same molecular weight. Nor does surface charge appear to be the basis for selective incorporation, since both BSA and vitellogenin are negatively charged proteins.
Up to a concentration of approximately 10 mg.m1-1, BSA did not measurably perturb the incorporation of vitellogenin, regardless of the latter's concentration. On the other hand, the addition of vitellogenin to the medium stimulated rather than competed with BSA incorporation. However, the stimulation of BSA uptake we observed was not nearly so great as that observed by Ryser (14) for the effect of polybasic compounds on albumin incorporation by cells in tissue culture; therefore a different mechanism may be involved.
The available evidence indicates that the incorporation of vitellogenin by oocytes involves only a micropinocytotic process in X. laevis (5, 21) as well as in other animals (12, 16, 19) . Presumptive evidence has also been obtained for vitellogenin binding sites on the oocyte membrane (22, 23) . We propose here that incorporation of external protein by the oocyte initially involves the association of that protein with membrane receptor sites followed by micropinocytosis of the bound complex.
BSA, at least up to a concentration of 10 mg,ml-~, does not appear to compete effectively for the vitellogenin binding sites. At higher concentrations, some apparent competition is observed (Fig. 4) , but this effect is difficult to interpret because the viscosity of the medium becomes rather high at these concentrations (17) and may perturb the sequestering processes. In the absence of vitellogenin, the rate of BSA uptake as a function of concentration follows a sigmoid curve (Fig. 5 a) . The simplest interpretation of this effect is that a basal level of micropinocytosis takes place in the absence of vitellogenin, and that any protein external to the oocyte is adventitiously engulfed by this process. Above a certain level (ca. 0.5 mg.ml -~ in the case of BSA), external protein begins to promote micropinocytosis. On the other hand, vitellogenin, because it binds to the receptor sites with high avidity, promotes micropinocytosis at very low concentrations (probably by at least several orders of magnitude lower than BSA) so that a sigmold-type curve of uptake as a function of concentration is more difficult to demonstrate experimentally. Also, regardless of the external concentration of BSA, the addition of vitellogenin to the medium would promote additional micropinocytosis and adventitious engulfment of external BSA.
